These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4744574)

  • 1. Genetic factors in Hodgkin's disease: association with a disease-susceptibility locus (DSA) in the HL-A region.
    Bodmer WF
    Natl Cancer Inst Monogr; 1973 May; 36():127-34. PubMed ID: 4744574
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of HL-A antigens in patients with Hodgkin's disease and their families.
    Forbes JF; Morris PJ
    J Clin Invest; 1972 May; 51(5):1156-63. PubMed ID: 5020429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 3. Immunology. Invited discussion: Genetic factors in immune responsivess.
    McDevitt HO
    Natl Cancer Inst Monogr; 1973 May; 36():135-6. PubMed ID: 4270376
    [No Abstract]   [Full Text] [Related]  

  • 4. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
    Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HLA-DRB1 allele, HLA-DRB1*0465, was identified in a Hodgkin's lymphoma cell line.
    Witter K; Mautner J; Volgger A; Zahn R; Kauke T
    Tissue Antigens; 2008 Mar; 71(3):257-8. PubMed ID: 18194364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications.
    Schneiderman MA
    Natl Cancer Inst Monogr; 1973 May; 36():169-70. PubMed ID: 4744575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Editorial: HL-A and diseases].
    Dausset J
    Nouv Presse Med; 1974 Mar; 3(9):499-501. PubMed ID: 4822147
    [No Abstract]   [Full Text] [Related]  

  • 8. [HL-A antigens in patients with Hodgkin's disease].
    Maczyńska-Rusiniak B; Zupańska B
    Acta Haematol Pol; 1975; 6(4):267-71. PubMed ID: 1199675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease.
    Oza AM; Tonks S; Lim J; Fleetwood MA; Lister TA; Bodmer JG
    Cancer Res; 1994 Oct; 54(19):5101-5. PubMed ID: 7923125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HL-A antigens in Hodgkin's disease and multiple myeloma. Increased frequency of W18 in both diseases.
    Bertrams J; Kuwert E; Böhme U; Reis HE; Gallmeier WM; Wetter O; Schmidt CG
    Tissue Antigens; 1972; 2(1):41-6. PubMed ID: 4116681
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of Hodgkin's disease: a review.
    Cartwright RA; Watkins G
    Hematol Oncol; 2004 Mar; 22(1):11-26. PubMed ID: 15152367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphocyte stimulation of healthy probands with a "Hodgkin's HL-A type" (author's transl)].
    Tittor W; Kredel L; Röck E
    Klin Wochenschr; 1976 Oct; 54(20):995-9. PubMed ID: 979080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Hodgkin's disease: an environmental and genetic disorder.
    Vianna NJ; Davies JN; Polan AK; Wolfgang P
    Lancet; 1974 Oct; 2(7885):854-7. PubMed ID: 4137662
    [No Abstract]   [Full Text] [Related]  

  • 14. International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Epidemiology, virology, and immunology.
    Miller RW
    Natl Cancer Inst Monogr; 1973 May; 36():351-2. PubMed ID: 4744594
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
    Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage disequilibrium between HL-A7 and the MLC specificity Pi.
    Albert ED; Mempel W; Grosse-Wilde H
    Transplant Proc; 1973 Dec; 5(4):1551-3. PubMed ID: 4130065
    [No Abstract]   [Full Text] [Related]  

  • 17. [Human histocompatibility antigens (HL-A-antigens). Genetic studies and identification of "new" HL-A-antigens].
    Thorsby E
    Nord Med; 1970 Feb; 83(7):193-7. PubMed ID: 5444941
    [No Abstract]   [Full Text] [Related]  

  • 18. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.
    Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K
    Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HL-A antigens in Hodgkin's disease; histopathologic and clinical correlations.
    Graff KS; Simon RM; Yankee RA; DEVita VT; Rogentine GN
    J Natl Cancer Inst; 1974 Apr; 52(4):1087-90. PubMed ID: 4826579
    [No Abstract]   [Full Text] [Related]  

  • 20. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    Mov Disord; 1994 May; 9(3):337-9. PubMed ID: 7913740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.